These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 1718758
1. Major histocompatibility complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mice: a model for B cell chronic lymphocytic leukemia and autoimmune disease. Okada T, Takiura F, Tokushige K, Nozawa S, Kiyosawa T, Nakauchi H, Hirose S, Shirai T. Eur J Immunol; 1991 Nov; 21(11):2743-8. PubMed ID: 1718758 [Abstract] [Full Text] [Related]
2. Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia. Shirai T, Okada T, Hirose S. Ann N Y Acad Sci; 1992 May 04; 651():509-26. PubMed ID: 1376072 [Abstract] [Full Text] [Related]
3. Genetic factors predisposing to B-CLL and to autoimmune disease in spontaneous murine model. Hirose S, Hamano Y, Shirai T. Leukemia; 1997 Apr 04; 11 Suppl 3():267-70. PubMed ID: 9209361 [Abstract] [Full Text] [Related]
4. Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice. Hirose S, Ueda G, Noguchi K, Okada T, Sekigawa I, Sato H, Shirai T. Eur J Immunol; 1986 Dec 04; 16(12):1631-3. PubMed ID: 2949983 [Abstract] [Full Text] [Related]
5. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages. Okamoto H, Nishimura H, Shinozaki A, Zhang D, Hirose S, Shirai T. Jpn J Cancer Res; 1993 Dec 04; 84(12):1273-8. PubMed ID: 7507474 [Abstract] [Full Text] [Related]
6. The H2 haplotype regulates the distribution of B cells into B-1a, B-1b and B-2 subsets. Pers JO, Jamin C, Lydyard PM, Charreire J, Youinou P. Immunogenetics; 2002 Jun 04; 54(3):208-11. PubMed ID: 12073150 [Abstract] [Full Text] [Related]
7. Mixed haplotype A beta Z/A alpha d class II molecule in (NZB x NZW)F1 mice detected by T cell clones. Gotoh Y, Takashima H, Noguchi K, Nishimura H, Tokushima M, Shirai T, Kimoto M. J Immunol; 1993 Jun 01; 150(11):4777-87. PubMed ID: 8496588 [Abstract] [Full Text] [Related]
10. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Merino R, Fossati L, Lacour M, Lemoine R, Higaki M, Izui S. Eur J Immunol; 1992 Feb 01; 22(2):295-9. PubMed ID: 1537372 [Abstract] [Full Text] [Related]
15. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus. Wen X, Zhang D, Kikuchi Y, Jiang Y, Nakamura K, Xiu Y, Tsurui H, Takahashi K, Abe M, Ohtsuji M, Nishimura H, Takatsu K, Shirai T, Hirose S. Eur J Immunol; 2004 Oct 01; 34(10):2740-9. PubMed ID: 15368290 [Abstract] [Full Text] [Related]
16. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice. Carlsten H, Holmdahl R, Tarkowski A. Immunology; 1991 Jun 01; 73(2):186-90. PubMed ID: 2071164 [Abstract] [Full Text] [Related]
18. Effects of major histocompatibility complex on autoimmune disease of H-2-congenic New Zealand mice. Hirose S, Kinoshita K, Nozawa S, Nishimura H, Shirai T. Int Immunol; 1990 Jun 01; 2(11):1091-5. PubMed ID: 2083229 [Abstract] [Full Text] [Related]
19. Correlations of autoimmunity with H-2 and T cell receptor beta chain genotypes in (NZB X NZW) F2 mice. Noonan DJ, McConahey PJ, Cardenas GJ. Eur J Immunol; 1990 May 01; 20(5):1105-10. PubMed ID: 1972678 [Abstract] [Full Text] [Related]
20. Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model. Concomitant regulation by MHC and non-MHC genes. Caspi RR, Grubbs BG, Chan CC, Chader GJ, Wiggert B. J Immunol; 1992 Apr 15; 148(8):2384-9. PubMed ID: 1560198 [Abstract] [Full Text] [Related] Page: [Next] [New Search]